Cloud-based ligand-guided virtual screening with deep-learning-enhanced docking identifies a micromolar CXCR4 antagonist.

Xolremdi (mavorixafor) - X4 Pharma, Norgine

http://www.ncbi.nlm.nih.gov/pubmed/42622749

Hua Zhu; Junsong Han; Kian Chee Chong; Monsin Sangsawat; Nonthaneth Nalinratana; Opa Vajragupta; Pornchai Rojsitthisak; Worathat Thitikornpong; Yanting Ding; Yichun Xu; Zhai Cai

Aug 21, 2026